Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · IEX Real-Time Price · USD
2.700
+0.050 (1.89%)
At close: Jul 19, 2024, 4:00 PM
2.690
-0.010 (-0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Eledon Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ELDN stock have an average target of 11.67, with a low estimate of 9.00 and a high estimate of 16. The average target predicts an increase of 332.22% from the current stock price of 2.70.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 4, 2024.
Analyst Ratings
The average analyst rating for ELDN stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +492.59% | Jun 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +492.59% | May 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $16 | Strong Buy | Maintains | $13 → $16 | +492.59% | May 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +381.48% | Mar 22, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $13 | Strong Buy | Reiterates | $13 | +381.48% | Nov 13, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
51.00M
EPS This Year
-1.17
from -1.64
EPS Next Year
-0.64
from -1.17
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | 105.0M | n/a | n/a | 18.3M |
Avg | n/a | 51.0M | n/a | n/a | 17.7M |
Low | n/a | n/a | n/a | n/a | 17.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.83 | 0.48 | -0.77 | -0.91 | -0.86 |
Avg | -1.17 | -0.64 | -0.74 | -0.89 | -0.84 |
Low | -1.44 | -1.62 | -0.72 | -0.85 | -0.80 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.